Byline |
A Elliott1 *, J Scwartz2 , J Wang3 , A Shetty4 , D O''Neal5 , C Bourgoyne6 , J Hazle7 and R Stafford8 , (1) M.D. Anderson Cancer Center, Houston, TX, (2) Nanospectra Biosciences, Inc., Houston, TX, (3) Nanospectra Biosciences, Inc., Houston, TX, (4) The University of Texas M.D.Anderson Cancer Center, Houston, Texas, (5) Louisiana Tech. University, Ruston, Louisiana, (6) , Ruston, Louisiana, (7) UT MD Anderson Cancer Center, Houston, TX, AF, (8) UT MD Anderson Cancer Center, Houston, TX
|